Cerebral achromatopsia secondary to cerebral amyloid angiopathy
Michael D. Woods,
Pamela Davila Siliezar,
Noor Laylani,
Elliott R. Friedman,
Steve H. Fung,
Andrew G. Lee
Affiliations
Michael D. Woods
Texas A and M School of Medicine, Bryan, TX, USA
Pamela Davila Siliezar
Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA
Noor Laylani
Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA
Elliott R. Friedman
Neuroradiology, Houston Methodist Hospital, Houston Radiology Associated, Houston, TX, USA
Steve H. Fung
Texas A and M School of Medicine, Bryan, TX, USA; Neuroradiology, Houston Methodist Hospital, Houston Radiology Associated, Houston, TX, USA; Department of Radiology, Weill Cornell Medicine, New York, NY, USA
Andrew G. Lee
Texas A and M School of Medicine, Bryan, TX, USA; Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA; Departments of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medicine, New York, NY, USA; Department of Ophthalmology, University of Texas Medical Branch, Galveston, TX, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA; Corresponding author. Department of Ophthalmology - Blanton Eye Institute, Houston Methodist Hospital, 6560 Fannin St. Ste 450, Houston, TX, 77030, USA.
